Who Grade Iii Glioma

• CLINICAL_TRIALS research · 2026-04-22
  Clinical Trial Update: Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant [Phase 2]

  Phase 2 clinical trial exploring ribociclib with everolimus or with temozolomide for high-grade gliomas and related diffuse gliomas; recruit…

• CLINICAL_TRIALS research · 2026-03-17
  Clinical Trial Update: ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors [Phase 1]

  Phase 1 clinical trial evaluating ONC206 for newly diagnosed and recurrent diffuse midline gliomas and other recurrent malignant CNS tumors;…

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion [EARLY_Phase 1]

  A Phase 1 study assessing lorlatinib for newly diagnosed high-grade gliomas with ALK or ROS1 fusions; currently recruiting.

• CLINICAL_TRIALS trial_result · 2026-03-11
  Clinical Trial Update: Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms [Phase 2]

  A Phase 2 clinical trial evaluating Fluoroethyltyrosine for the evaluation of intracranial neoplasms, including low-grade glioma and recurre…

• CLINICAL_TRIALS research · 2026-03-02
  Clinical Trial Update: Mind-Body Intervention in Glioma Couples [NA]

  Clinical trial update for a mind-body intervention targeting glioma patients and their partners. The study is currently active but not recru…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-01-20
  Clinical Trial Update: Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors [NA]

  This ClinicalTrials.gov entry describes a study testing a customized neuro-imaging referenced symptom video intended to reduce patient and c…

• CLINICAL_TRIALS research · 2025-12-17
  Clinical Trial Update: Combination Therapy for the Treatment of Diffuse Midline Gliomas [Phase 2]

  A Phase 2 clinical trial update describes a combination therapy for diffuse midline gliomas, including H3 K27M-mutant DMG and DIPG, with the…

• CLINICAL_TRIALS trial_result · 2024-10-30
  Clinical Trial Update: Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma [Phase 1]

  Phase 1 trial evaluates genetically modified T-cells (CAR-T) in patients with recurrent or refractory malignant glioma. Results have been po…

• CLINICAL_TRIALS trial_result · 2024-04-29
  Clinical Trial Update: Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas [Phase 1]

  Phase 1 clinical trial update evaluating safety and preliminary efficacy of carboxylesterase-expressing allogeneic neural stem cells in comb…

• CLINICAL_TRIALS trial_result · 2021-10-28
  Clinical Trial Update: Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma [Phase 2]

  A Phase 2 trial evaluating a combination of sorafenib, valproic acid, and sildenafil in patients with recurrent high-grade glioma has comple…